###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 62 70 <span type="species:ncbi:9606">Patients</span>
PHEX Gene Mutations and Genotype-Phenotype Analysis of Korean Patients with Hypophosphatemic Rickets
###end article-title 0
###begin p 1
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 108 112 108 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 751 755 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 868 872 868 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
###xml 246 254 <span type="species:ncbi:9606">patients</span>
X-linked hypophosphatemic rickets (XLH) results from mutations in the PHEX gene. Mutational analysis of the PHEX gene in 15 unrelated Korean patients with hypophosphatemic rickets revealed eight mutations, including five novel mutations, in nine patients: two nonsense mutations, two missense mutations, one insertion, and three splicing acceptor/donor site mutations. Of these, c.64G>T, c.1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations. To analyze the correlation between genotype and phenotype, phenotypes were compared between groups with and without a mutation, in terms of mutation location, mutation type, and sex. Skeletal disease tended to be more severe in the group with a mutation in the C-terminal half of the PHEX gene, but no genotype-phenotype correlation was detected in other comparisons. Further extensive studies of the PHEX gene mutations and analyses of the genotype-phenotype relationships are required to understand PHEX function and the pathogenesis of XLH.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
Familial hypophosphatemic rickets (FHR) is defined as a group of disorders caused by a defect in renal phosphate transport, leading to phosphate wasting and hypophosphatemia. FHR is also characterized by the abnormal regulation of vitamin D metabolism, resulting in inappropriately normal 1, 25-dihydroxyvitamin D concentrations despite hypophosphatemia (1). X-linked hypophosphatemic rickets (XLH; MIM 307800), the most common form of FHR, is characterized by rickets and osteomalacia, lower-extremity deformities, short stature, bone pain, dental abnormalities, and abnormal vitamin D metabolism (2). Other less common forms of FHR include autosomal dominant hypophosphatemic rickets (ADHR), hereditary hypophosphatemic rickets with hypercalciuria, and tumor-induced osteomalacia.
###end p 3
###begin p 4
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 424 425 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 926 927 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
XLH results from loss-of-function mutations in the PHEX gene (phosphate-regulating gene with homologies to endopeptidases on the X chromosome), located on Xp22.1 (3). PHEX is a member of the M13 family of type II cell-surface-membrane zinc-dependent proteases, which include neprilysin (NEP), two endothelin-converting enzymes (ECE-1 and -2), the KELL antigen, and damage-induced neuronal endopeptidase/X-converting enzyme (4). PHEX cDNA has been cloned (5) and consists of 22 exons spanning 2,247 bp of genomic sequence. Seventeen of the 22 exons are less than 130 bp long (2). PHEX and NEP share conserved genomic structures. Like NEP, PHEX includes a short N-terminal tail, a single N-terminal hydrophobic region corresponding to a transmembrane domain, a highly conserved zinc-binding domain in exons 17 and 19, and several conserved cysteine residues and amino acids that, in NEP, are involved in its catalytic activity (1).
###end p 4
###begin p 5
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 158 166 <span type="species:ncbi:9606">patients</span>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
Several studies have identified mutations in the PHEX gene in individuals with XLH. Recently, we studied the clinical and molecular characteristics of Korean patients with XLH. In this report, we describe eight different PHEX mutations identified in 15 unrelated Korean patients with hypophosphatemic rickets, including five novel mutations.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin title 7
Subjects
###end title 7
###begin p 8
###xml 689 695 689 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 366 374 <span type="species:ncbi:9606">patients</span>
###xml 500 508 <span type="species:ncbi:9606">patients</span>
###xml 520 528 <span type="species:ncbi:9606">children</span>
###xml 590 597 <span type="species:ncbi:9606">patient</span>
###xml 649 656 <span type="species:ncbi:9606">patient</span>
This study included 15 patients and five of their family members, aged from 20 months to 60 yr (average, 22 yr). Of the 15 patients, five had a family history of XLH, four were sporadic cases, and the other six were unknown. Diagnoses were made based on clinical, radiological, and laboratory findings by specialists at the Korea University Guro Hospital. Of the 15 patients, four were male and 11 were female. Overall, there were five male and 15 female individuals (including family members). Five patients were young children. Of the five family members evaluated, three were related to patient 1-1 (mother, maternal aunt, and cousin) and two to patient 7-1 (mother and maternal aunt) (Fig. 1).
###end p 8
###begin p 9
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 238 239 238 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 272 280 <span type="species:ncbi:9606">patients</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
For phenotypic analyses, the medical records and histories of the patients were reviewed retrospectively. The severity of the skeletal disease was assessed by orthopedic surgeons and was classified as mild, moderate, or severe (Table 1) (1). Osteotomies were performed in patients who complained of gait disturbance caused by either pain or fatigue. For the two patients with affected family members, the families were analyzed as a unit. They were classified as having mild disease if all members had mild disease, as having moderate disease if at least one member had moderate disease, or as having severe disease if at least one member had severe disease.
###end p 9
###begin p 10
###xml 314 321 314 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
Although there are no widely accepted criteria with which to describe the severity of dental disease manifestations in patients with rickets, we simplified the assessment of dental disease severity by describing it in terms of the number of dental abscess lesions and the treatments performed for these abscesses (Table 1). The data on dental diseases were collected based on the histories of the patients.
###end p 10
###begin title 11
Mutation analysis
###end title 11
###begin p 12
###xml 396 400 387 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 56 64 <span type="species:ncbi:9606">patients</span>
###xml 100 107 <span type="species:ncbi:9606">patient</span>
Informed consent for DNA analysis was obtained from the patients or their parents, depending on the patient's age. Genomic DNA was extracted from the peripheral blood using the G-DEXtrade mark II Genomic DNA Extraction Kit (Intron, Seongnam, Korea), according to the manufacturer's protocol. Screening for mutations was performed with PCR amplification and direct sequencing. All 22 exons of the PHEX gene, including at least 40 bp of the exon-intron flanking regions, were amplified by PCR. Sequencing was performed with a Dynamictrade mark ET Dye Terminator Kit (GE Healthcare, Buckinghamshire, U.K.) and a MegaBACE 500 Genetic Analyzer (GE Healthcare), according to the manufacturer's instructions. Base calling of the sample files was performed with Cimarron Base Caller version 3.12 software (GE Healthcare).
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 257 262 <span type="species:ncbi:9606">Human</span>
The PHEX genes of 50 normal female individuals were also analyzed to confirm that the sequence variations in the PHEX gene identified in this study were not polymorphisms but real pathogenic mutations. Novel mutations were defined by their absence from the Human Gene Mutation Database () and from mutations previously reported in PubMed (). The functional consequences of novel splice variants were predicted with the Automated Splice Site Analyses program on the web () (6).
###end p 13
###begin title 14
Statistical analysis
###end title 14
###begin p 15
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The Wilcoxon rank-sum test and the two-tailed Fisher's exact test were used to calculate p values and to determine whether the differences between the phenotypes of the genotype groups were statistically significant. We used a significance level of p<0.10 because the sample size was small, in accordance with previously published analyses of small samples (1, 7).
###end p 15
###begin title 16
RESULTS
###end title 16
###begin p 17
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 144 152 <span type="species:ncbi:9606">patients</span>
###xml 218 226 <span type="species:ncbi:9606">patients</span>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 382 390 <span type="species:ncbi:9606">patients</span>
In a total of 15 patients, the average ages at onset and diagnosis were 31 months and 90 months, respectively. The male: female ratio among the patients was 4:11 (Table 2, 3). Laboratory findings were available for 10 patients: seven patients with a PHEX gene mutation and three patients without a PHEX gene mutation. The mean total serum calcium and phosphorus levels for those 10 patients were 9.2+/-0.4 mg/dL and 2.2+/-0.8 mg/dL, respectively.
###end p 17
###begin p 18
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 239 245 239 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Eight different mutations in the PHEX gene were detected in nine patients of the 15 unrelated Korean patients (60%). Of these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identified in this study (Fig. 2).
###end p 18
###begin p 19
###xml 680 686 680 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
Inspection of the mutations revealed that c.1363G>T (p. Glu455X) and c.1699C>T (p.Arg567X) were nonsense mutations, and that c.1601C>T (p.Pro534Leu) and c.64G>T (p. Ala22Ser) were missense mutations. One mutation, c.466_467 insAC, was an insertion that causes a frameshift leading to a downstream stop codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/donor sites; c.1174-1G>A was detected in two unrelated Korean patients. Two mutations, c.64G>T and c.466_467insAC, are located in the N-terminal half and the other six mutations are in the C-terminal half of the PHEX protein (Fig. 3). For novel splice variants, automated splicing mutation analysis predicted that the c.1174-1G>A variation decreases the binding energy of the natural splice acceptor site to 0.5% and thus abolishes the site, and that the c.1768+5G> A variation decreases the binding energy of the natural splice site to 8.7% of its initial energy and thus weakens the original donor splice site.
###end p 19
###begin p 20
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 267 274 267 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 392 399 392 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 503 504 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 513 520 513 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 108 116 <span type="species:ncbi:9606">patients</span>
The phenotypes of the 15 patients and of all available family members (including five family members of two patients) were analyzed. The average age at onset was 64 months in the group with a PHEX mutation and 17 months in the group without a PHEX mutation (p=0.049; Table 4). No significant correlation was found between the severity of the skeletal or dental disease and the mutation type (Table 5). Skeletal disease was more severe in the group with a mutation in the C-terminal half of the protein (p=0.083) (Table 5).
###end p 20
###begin title 21
DISCUSSION
###end title 21
###begin p 22
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 334 335 334 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 650 651 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 679 683 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 766 768 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 982 984 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 986 988 986 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
###xml 660 668 <span type="species:ncbi:9606">patients</span>
XLH is the most common form of FHR and results from a mutation in the PHEX gene. In our study, the mutation detection rates in the PHEX gene were 60% in familial cases and 25% in sporadic cases among patients with XLH. These are similar to the results of previous studies: 51-86% in familial cases and 22-57% in sporadic cases (1, 2, 8-10), except for one Finnish study, in which the mutation detection rate was 100% for familial cases and 93% for sporadic cases (11). The lower mutation detection rate in sporadic cases might be explained by the fact that the sporadic disease can be caused by other types of hypophosphatemic rickets, such as ADHR (1). Thus, patients without a PHEX gene mutation should be screened for mutations in fibroblast growth factor 23 (4, 12). Because only the 22 exons were screened for mutations in our study, mutations in the promoter, introns, 5'-untranslated region, 3'-untranslated region, and target sequences of miRNAs might have been overlooked (10, 13).
###end p 22
###begin p 23
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 64 65 64 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 399 400 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
The c.1601C>T mutation has been observed in many studies (1, 2, 8-10, 14). This region may be prone to mutation, as suggested by Dixon et al. (9). Pro534 is encoded by one of 47 CpGs in the PHEX gene (15). The p.Pro534Leu mutation seems to affect the local hydrophobicity of the gene product, because leucine is aliphatic (2), and the substituted proline is conserved in ECE-1 and the KELL antigen (8). The c.64G> T mutation, a new mutation detected in this study, occurs at the site of the putative transmembrane domain. No mutation was identified in the putative transmembrane domain in a previous study (9).
###end p 23
###begin p 24
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 208 215 208 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 487 491 487 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
The marked difference in the average age at onset between the groups with and without a PHEX mutation may be the result of the small sample size and the late age at onset of one family member, subject 7-2 in Table 2. Severe phenotypes usually begin to manifest at an earlier age than do mild phenotypes. However, early mean age of onset and disease severity were not correlated in this study. Furthermore, the difference in the average age at onset between the groups with and without a PHEX gene mutation was not statistically significant in a previous study (10). A larger sample size is required to confirm these data.
###end p 24
###begin p 25
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 565 566 565 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 198 206 <span type="species:ncbi:9606">Patients</span>
The number of mutations in the C-terminal half of PHEX was 3.5 times greater than the number in the N-terminal half in this study, and 1.7 times greater than that reported by Filisetti et al. (15). Patients with a mutation in the C-terminal half of the protein had more severe skeletal disease in this study. The N-terminal region contains the cytoplasmic domain, transmembrane domain, and five conserved cysteine residues, whereas the C-terminal region contains two zinc-binding motifs in exons 17 and 19, five conserved cysteine residues, and the catalytic site (2, 5, 15, 16). No agreement has yet been reached regarding the correlation between the disease phenotypes and PHEX mutation locations, including those in this study (1, 8, 17). Holm et al. (1) identified a trend between truncating mutations and more severe skeletal disease in a familial group (p=0.072). However, Cho et al. (10) reported no correlation between phenotype and mutation type, consistent with the results of this study.
###end p 25
###begin p 26
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
The gene dosage effect was also analyzed in the nine patients with PHEX mutations, but no significant correlation was found (data not shown). Because the sample was small, we did not divide the group into prepubertal and postpubertal age groups. However, Holm et al. (1) reported a trend towards an association between male sex and more severe dental disease. Because XLH is inherited as an X-linked dominant trait, females should usually be less severely affected than males. However, no gene dosage effect was observed in this study or in a previous study (10), although our sample was too small to allow any conclusion to be drawn. Previous studies have indicated that the PHEX gene is subject to random inactivation, but it has also been reported that some alleles escape inactivation (18, 19).
###end p 26
###begin p 27
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Hypophosphatemic rickets often exhibit high pulp horns, large pulp chambers, and dentinal clefts. Although odontoblast function is normal, hypophosphatemia leads to dysplastic and poorly mineralized areas of the interglobular dentin (20). We classified dental diseases according to the number of dental abscess lesions and the treatments performed for these abscesses. However, no genotype-phenotype correlation was detected in comparisons of dental disease severity.
###end p 27
###begin p 28
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 364 372 <span type="species:ncbi:9606">patients</span>
In this study, although skeletal disease tended to be more severe in the group with a mutation in the C-terminal half of PHEX, the sample size was too small to draw a definitive conclusion. Therefore, identification of the mutation in the PHEX gene may have a limited prognostic value in patients with XLH. Other factors may exist that determine the phenotypes of patients with XLH.
###end p 28
###begin article-title 29
Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets
###end article-title 29
###begin article-title 30
###xml 28 33 <span type="species:ncbi:9606">human</span>
Genomic organization of the human PEX gene mutated in X-linked dominant hypophosphatemic rickets
###end article-title 30
###begin article-title 31
###xml 61 69 <span type="species:ncbi:9606">patients</span>
A gene (PEX) with homologies to endopeptidases in mutated in patients with X-linked hypophosphatemic rickets
###end article-title 31
###begin article-title 32
FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization
###end article-title 32
###begin article-title 33
###xml 30 35 <span type="species:ncbi:9606">human</span>
Expression and cloning of the human X-linked hypophosphatemia gene cDNA
###end article-title 33
###begin article-title 34
Automated splicing mutation analysis by information theory
###end article-title 34
###begin article-title 35
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
###end article-title 35
###begin article-title 36
Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)
###end article-title 36
###begin article-title 37
Mutational analysis of PHEX gene in X-linked hypophosphatemia
###end article-title 37
###begin article-title 38
###xml 70 78 <span type="species:ncbi:9606">children</span>
A clinical and molecular genetic study of hypophosphatemic rickets in children
###end article-title 38
###begin article-title 39
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Identification of fifteen novel PHEX gene mutations in Finnish patients with hypophosphatemic rickets
###end article-title 39
###begin article-title 40
Disorders of phosphate metabolism pathomechanisms and management of hypophosphataemic disorders
###end article-title 40
###begin article-title 41
Approaches to microRNA discovery
###end article-title 41
###begin article-title 42
###xml 36 44 <span type="species:ncbi:9606">patients</span>
X-linked hypophosphatemia in Polish patients 1. Mutations in the PHEX gene
###end article-title 42
###begin article-title 43
Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues
###end article-title 43
###begin article-title 44
Disease-causing missense mutations in the PHEX gene interfere with membrane targeting of the recombinant protein
###end article-title 44
###begin article-title 45
###xml 36 44 <span type="species:ncbi:9606">patients</span>
X-linked hypophosphatemia in Polish patients 2. Analysis of clinical features and genotype-phenotype correlation
###end article-title 45
###begin article-title 46
X chromosome inactivation pattern in female carriers of X linked hypophosphataemic rickets
###end article-title 46
###begin article-title 47
X-inactivation profile reveals extensive variability in X-linked gene expression in females
###end article-title 47
###begin article-title 48
X-linked hypophosphatemia: dental and histologic findings
###end article-title 48
###begin p 49
###xml 24 27 24 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 34 37 34 37 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 13 21 <span type="species:ncbi:9606">patients</span>
Pedigrees of patients 1 (A) and 7 (B) with X-linked hypophosphatemic rickets.
###end p 49
###begin p 50
###xml 63 66 63 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 79 82 79 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 96 99 96 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(C)</bold>
###xml 111 114 111 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(D)</bold>
###xml 132 135 132 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(E)</bold>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 157 165 <span type="species:ncbi:9606">patients</span>
Direct sequencing results demonstrate novel mutations, c.64G>T (A), c.466insAC (B), c.1174-1G>A (C), c.1699C>T (D), and c.1768+5G>A (E), in the PHEX gene in patients with X-linked hypophosphatemic rickets.
###end p 50
###begin p 51
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Mutations of the PHEX gene identified in Korean patients with X-linked hypophosphatemic rickets. The putative transmembrane domain (TM), cysteine residues (C), and zinc-binding domains (Z) are shown below the boxes of the 22 exons. Novel mutations found in this study are shown in bold.
###end p 51
###begin p 52
Classification of phenotypic severity of skeletal and dental diseases
###end p 52
###begin p 53
N/A, not applicable.
###end p 53
###begin p 54
###xml 67 71 67 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Genotype and phenotype data for patients and family members with a PHEX gene mutation
###end p 54
###begin p 55
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 177 183 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8224;</sup>
*Reference sequences for PHEX, gDNA U82907, cDNA NM_000444. Mutation numbering is based on cDNA sequences. +1 corresponds to the first base of the translation initiation codon. daggerNovel mutations identified in this study. N/A, not applicable. U, unknown.
###end p 55
###begin p 56
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Genotype and phenotype information for patients without a PHEX gene mutation
###end p 56
###begin p 57
U, unknown.
###end p 57
###begin p 58
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Genotype-phenotype correlations in patients with and without a PHEX gene mutation
###end p 58
###begin p 59
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHEX</italic>
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Genotype-phenotype correlations in patients with a PHEX gene mutation in terms of mutation type
###end p 59
###begin p 60
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
*p<0.1 (0.083); p>0.1 for other parameters.
###end p 60

